Weekly Cosmetic Research Analysis
This week’s cosmetic-related literature highlights mechanistic and translational advances: a multi-tissue geroscience study (Nature Communications) identifies the RAGA–mTOR / SIRT3 axis as a sex-specific longevity target; large-scale human data (ACS Nano) show hydroxyl-terminated PEG largely evades pre-existing anti-PEG antibodies and reduces LNP complement activation, with clear implications for safer repeat-dosing formulations; and EV-based regenerative work (Bioengineering & Translational Med
Summary
This week’s cosmetic-related literature highlights mechanistic and translational advances: a multi-tissue geroscience study (Nature Communications) identifies the RAGA–mTOR / SIRT3 axis as a sex-specific longevity target; large-scale human data (ACS Nano) show hydroxyl-terminated PEG largely evades pre-existing anti-PEG antibodies and reduces LNP complement activation, with clear implications for safer repeat-dosing formulations; and EV-based regenerative work (Bioengineering & Translational Medicine) defines a miR-221-3p→DKK2→Wnt axis that promotes hair growth. Across the week, innovations span safer material chemistries, engineered biologics (EVs, recombinant collagen), and improved diagnostic/PK resources (skin proteomics, skin ultrasound) that are poised to influence cosmetic formulation, procedural safety, and translational clinical trials.
Selected Articles
1. Corylin promotes healthy aging via RAGA-mTOR suppression and sex-dependent activation of SIRT3.
Mid-life administration of the flavonoid Corylin improved metabolic, muscular, and functional phenotypes and extended median lifespan in female mice. Multi-omics analyses link these benefits to suppression of mTOR via interaction with RAGA and restoration of SIRT3-driven energy programs in females, supporting a sex-specific geroprotective mechanism.
Impact: Provides high-quality, multi-omics mechanistic evidence linking a botanical compound to sex-specific lifespan extension, identifying tractable molecular targets (RAGA–mTOR, SIRT3) with potential cosmetic and metabolic aging relevance.
Clinical Implications: Encourages target validation (RAGA–mTOR, SIRT3) in human pharmacokinetic/safety studies and sex-stratified early-phase trials for geroprotective or cosmetic anti-aging interventions before clinical adoption.
Key Findings
- Corylin extended median lifespan by 11.9% in female mice and improved metabolic, muscle, and functional measures.
- Multi-omics linked Corylin action to mTOR suppression via direct interaction with RAGA and restoration of SIRT3 and energy metabolism programs in females.
2. Hydroxyl-Terminated Polyethylene Glycol Evades Human Pre-existing Anti-polyethylene Glycol Antibodies.
In a large human cohort (n=1,970), pre-existing anti-PEG IgM binding was strongly influenced by PEG terminal chemistry: methoxy end-groups increased binding while hydroxyl-terminated PEG largely evaded it. Replacing MeO-PEG with OH-PEG on LNPs attenuated complement activation, improved serum stability, reduced mRNA leakage, and lowered immunogenicity—offering a clear materials-based path to safer repeat-dosing nanomedicines and topical/dermal formulations.
Impact: Large-scale human data linked to functional LNP assays define a practical, actionable formulation change (OH-PEG) to mitigate clinically relevant anti-PEG responses—high immediate relevance for nanomedicines, dermocosmetics, and repeat topical/infusional products.
Clinical Implications: Recommend consideration of OH-PEG substitution in PEGylated formulations and incorporation of anti-PEG antibody screening in high-risk/repeat-dosing contexts; prospective clinical studies should evaluate whether OH-PEG lowers infusion reactions and improves tolerability.
Key Findings
- Methoxy terminal groups enhanced pre-existing anti-PEG IgM binding across 1,970 human samples; OH-PEG largely evaded IgM binding.
- Substituting MeO-PEG with OH-PEG on LNPs reduced complement activation, improved serum stability, decreased mRNA leakage, and lowered immunogenicity in functional assays.
3. Extracellular vesicles of human transformed skin-derived precursors containing miR-221-3p promote hair growth through DKK2-mediated Wnt/
High-quality htSKP-derived extracellular vesicles (EVs) enriched in miR-221-3p promote proliferation of hair follicle stem cells and sustain anagen by suppressing DKK2 and activating Wnt signaling. Effects were validated across human cells, ex vivo follicles, and an in vivo murine alopecia model, positioning EV-delivered miR-221-3p/DKK2 as a candidate therapeutic axis for alopecia.
Impact: Demonstrates a specific, targetable miRNA-mediated mechanism (miR-221-3p → DKK2 → Wnt) with multi-system validation for hair regeneration—advances EV-based cosmetic/regenerative therapies toward translational testing.
Clinical Implications: Supports development of EV- or miRNA-based minimally invasive treatments for alopecia; priorities include GMP EV production, safety/oncogenicity assessment, dosing/delivery standardization, and early-phase human trials.
Key Findings
- htSKP-EVs enriched in miR-221-3p enhanced human hair follicle stem cell proliferation and overall follicle growth by activating Wnt signaling.
- miR-221-3p suppressed DKK2 in dermal papilla cells, sustaining anagen; findings validated in human cells, ex vivo human follicles, and a murine alopecia model.